We look forward to continuously support you with personalized, high-touch, global CRO services and regulatory expertise dedicated to (immuno-)oncology, orphan diseases and ATMPs as CATO SMS in 2020
CATO SMS is a full-service clinical and regulatory contract research organization (CRO), specializing in complex areas such as (immuno-)oncology, advanced therapeutics and orphan diseases. CATO SMS has a center of excellence solely dedicated to oncology. With our unique business model of integrating oncology drug development affairs and clinical operations, we cover the whole value chain from trial design to the setup, management, and completion of phase I to IV trials. We specialize in early phase, pediatric and immuno-oncology trials.
